© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
Author | Donald H. Batts, MD
Articles
Linezolid-A New Option for Treating Gram-Positive Infections
August 01, 2000
ByDonald H. Batts, MDThe increase in serious gram-positive infections has increased the need for treatment of gram-positive infections in patients with hematologic malignancies. Common gram-positive pathogens exhibit a variety of resistance
Current Issues in the Treatment of Resistant Bloodstream Infections
August 01, 2000
ByJames C. Wade, MD|Donald H. Batts, MD|John N. Greene, MD|David C. Linch, MD|Georg Maschmeyer, MD, PhD|Carole B. Miller, MD|Gary A. Noskin, MD|Patricia Ribaud, MD|Kenneth V. I. Rolston, MD|Kent A. Sepkowitz, MD|James A. Talcott, MDBloodstream infections cause significant morbidity and mortality for patients with hematologic malignancy. Antimicrobial drugs are the most reliable currently available treatment for infection, but several issues must be